BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 2nd Quarter - Termination (No Activity)

FENNEC PHARMA

via DANIEL A. MICA, LLC

2nd Quarter (Apr 1 - June 30) · 2017Posted Jul 17, 2017Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: FENNEC PHARMA
Description: Pharmaceutical Company
Location: North Carolina · United States of America

Registrant

Firm: DANIEL A. MICA, LLC
Description: Consulting
Location: Alexandria, VA, Virginia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

FENNEC PHARMA — Lobbying — Receipts Report